Interaction Between ABT-335, Rosuvastatin and Warfarin

NCT00487136 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Warfarin
DRUG: warfarin plus ABT-335 plus rosuvastatin 5 mg
DRUG: warfarin plus ABT-335 plus rosuvastatin 20 mg

Sponsor

AstraZeneca